MARSHALL WACE, LLP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,436,491
+252.1%
58,040
+302.7%
0.00%
+200.0%
Q3 2022$408,000
-57.8%
14,413
-66.9%
0.00%
-50.0%
Q2 2022$966,000
+101.7%
43,563
+198.8%
0.00%
+100.0%
Q4 2021$479,000
-74.8%
14,581
-66.8%
0.00%
-90.0%
Q4 2020$1,901,000
+37.2%
43,878
+10.8%
0.01%
+11.1%
Q3 2020$1,386,000
-29.2%
39,593
-28.3%
0.01%
-55.0%
Q1 2020$1,959,000
-76.5%
55,234
-68.4%
0.02%
-64.9%
Q4 2019$8,344,000
+261.4%
174,735
+145.2%
0.06%
+216.7%
Q3 2019$2,309,000
+1250.3%
71,260
+1817.1%
0.02%
+800.0%
Q4 2018$171,000
-63.0%
3,717
-32.3%
0.00%
-71.4%
Q2 2018$462,000
+103.5%
5,490
+97.9%
0.01%
-22.2%
Q1 2018$227,000
-64.6%
2,774
-71.1%
0.01%
-70.0%
Q3 2017$642,000
-49.6%
9,587
-68.6%
0.03%
+275.0%
Q4 2016$1,274,000
-77.6%
30,528
-71.6%
0.01%
-80.0%
Q3 2016$5,675,000
+1374.0%
107,423
+1033.9%
0.04%
+900.0%
Q1 2016$385,0009,4740.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders